In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Even as it chips away at Obamacare, the Trump administration is solidly behind state-based initiatives to cover high-cost patients, known as “reinsurance” programs. It approved two more last week. [ED NOTE: JULY 30-31]
Many insurers added surcharges to policies they sold to individuals last year to make up for a cut in federal funding. Now, federal officials suggest that states encourage insurers to sell policies without those surcharges outside of the marketplace to help people who don’t get a premium subsidy.
Advocates of the sweeping health law view this move by the Trump administration as its most recent act of sabotage. But not everyone views it as a mortal blow.
